Related Experiment Video
Updated: Apr 23, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Tuberculosis prevention]
M Abouda1, F Yangui1, M Triki1
1Service de pneumologie, hôpital des forces de sécurité intérieures, La Marsa, Tunisie.
Active tuberculosis screening is crucial for vulnerable populations, utilizing methods like chest X-rays and IGRAs. Proactive prevention strategies, including isoniazid treatment, are key to controlling the global spread of this disease.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Context:
- Global migration, drug-resistant Mycobacterium tuberculosis strains, and increased at-risk populations necessitate evolving tuberculosis prevention strategies.
- Traditional screening methods like chest X-ray and tuberculin skin tests remain valuable, particularly in high-prevalence areas.
- Interferon-gamma release assays (IGRAs) show promise for immunodeficient individuals, especially those with prior BCG vaccination.
Purpose:
- To highlight the evolving landscape of tuberculosis prevention and screening.
- To emphasize the need for active and targeted screening of vulnerable populations.
- To discuss the role of various diagnostic and treatment modalities in tuberculosis control.
Summary:
- Tuberculosis prevention relies on early detection and treatment, adapting to new challenges like migration and resistant strains.
- Active screening of vulnerable groups, alongside traditional methods (X-ray, TST) and newer assays (IGRAs), is essential.
- Preventive treatment with isoniazid and adherence to WHO Stop TB guidelines are critical for individual and collective health.
Impact:
- Improved detection rates in at-risk and immunodeficient populations.
- Potential reduction in tuberculosis morbidity and mortality through enhanced screening and treatment protocols.
- Strengthened national tuberculosis control programs aligned with global strategies.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

